Insider Shareholders with Direct Ownership of Taysha Gene Therapies, Inc. (TSHA)
This section provides a comprehensive overview of the insiders with direct ownership of Taysha Gene Therapies, Inc. (TSHA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Taysha Gene Therapies, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 293,814 | 549,095 | 8,871,747 $18.3 Million | 8 |
Jul 13, 2023
Reduced 0.06%
|
|
| 2,975,535 | 0 | 1,333,333 $2.75 Million | 7 |
Jun 27, 2024
Added 50.0%
|
|
|
Sean P. Nolan
Chief Executive Officer |
1,185,858 | 0 | 1,185,858 $2.44 Million | 2 |
Jan 02, 2024
Added 49.98%
|
| 488,109 | 0 | 1,098,601 $2.26 Million | 2 |
May 29, 2024
Added 4.29%
|
|
|
Sukumar Nagendran
President and Head of R&D |
897,843 | 0 | 897,843 $1.85 Million | 4 |
Jan 02, 2024
Added 49.03%
|
|
Kamran Alam
CHIEF FINANCIAL OFFICER |
615,334 | 99,288 | 840,937 $1.73 Million | 12 |
Feb 02, 2024
Reduced 0.15%
|
|
Suyash Prasad
CMO and Head of R&D |
3,844 | 142,000 | 530,589 $1.09 Million | 9 |
Jul 06, 2022
Reduced 1.66%
|
| 163,331 | 0 | 163,331 $336,461 | 3 |
May 29, 2024
Added 23.16%
|
|
| 49,220 | 0 | 49,220 $101,393 | 1 |
May 29, 2024
Added 50.0%
|
|
| 49,220 | 0 | 49,220 $101,393 | 1 |
May 29, 2024
Added 50.0%
|